Science Explorer Interactive view Map
Company · Waltham · United States

Xilio Therapeutics (United States)

xiliotx.comROR OpenAlex
Research works
33
fractional, all time
Citations
482
14.7 per fractional work
Top-10% rate
7.9%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Xilio Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.60× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 12.73× its world share, 3 worksImmunology and Micro…Neuroscience: 1.68× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.41× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.07× its world share, 0 worksChemistryEngineering: 0.20× its world share, 1 worksEngineeringMaterials Science: 0.14× its world share, 0 worksMaterials ScienceHealth Professions: 0.28× its world share, 0 worksHealth ProfessionsMedicine: 2.75× its world share, 12 worksMedicineSocial Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.7×. Every wedge is a field page.

Who are the top researchers at Xilio Therapeutics (United States)?

Ranked on the composite score, Kerri Smith lead among researchers whose main affiliation is Xilio Therapeutics (United States).

  1. 1 Kerri Smith United States · #1,023,098 worldwide 38 citations · 44 works
All ranked researchers at Xilio Therapeutics (United States)

Which keywords describe research at Xilio Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Fc Receptors, Therapeutic Antibodies, Tumor Regression, Tumor Microenvironment, Inflammation and Innate Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Immunotherapy4▲ 23×4 topics
  2. Cancer Immunotherapy3▲ 90×2 topics
  3. Fc Receptors3▲ 222×1 topic
  4. Therapeutic Antibodies3▲ 174×1 topic
  5. Tumor Regression3▲ 104×2 topics
  6. Inflammation2▲ 4.6×10 topics
  7. Tumor Microenvironment2▲ 19×3 topics
  8. Innate Immunity2▲ 23×2 topics
  9. CAR T Cells2▲ 100×1 topic
  10. Cancer Therapy2▲ 13×7 topics
  11. Chimeric Antigen Receptor2▲ 100×1 topic
  12. Tumor Targeting2▲ 40×2 topics
  13. Antigen Presentation2▲ 74×1 topic
  14. Dendritic Cells2▲ 73×1 topic
  15. Immunity2▲ 16×2 topics
  16. Cancer1▲ 4.8×9 topics
  17. Gene Therapy1▲ 29×2 topics
  18. Immune Checkpoint Blockade1▲ 48×1 topic
  19. PD-1 and PD-L11▲ 48×1 topic
  20. Angiogenesis1▲ 15×4 topics
  21. Targeted Therapy1▲ 22×4 topics
  22. Breast Cancer1▲ 19×4 topics

Which research topics does Xilio Therapeutics (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.

Monoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksCAR-T cell therapy research: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCancer Research and Treatments: 1 fractional worksCancer Genomics and Diag…1Cancer Genomics and Diagnostics: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksMicrotubule and mitosis dynamics: 1 fractional worksCytokine Signaling Pathways and Interactions: 1 fractional worksCancer-related Molecular Pathways: 1 fractional works
Radiology, Nuclear Medicine and ImagingOncologyImmunologyBiotechnology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Cancer Research and Treatments Biotechnology 1 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 1 works
  7. 7 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  8. 8 Microtubule and mitosis dynamics Cell Biology 1 works
  9. 9 Cytokine Signaling Pathways and Interactions Oncology 1 works
  10. 10 Cancer-related Molecular Pathways Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.3%not open50.7%

World: 28% of research is openly available.

with international co-authors15.0%domestic only85.0%

World: 19% is written across borders.

How has Xilio Therapeutics (United States)'s research output changed?

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.